Indoco Remedies Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 4,390.8 million compared to INR 4,287.5 million a year ago. Revenue was INR 4,523 million compared to INR 4,286.6 million a year ago. Net income was INR 227 million compared to INR 258.1 million a year ago. Basic earnings per share from continuing operations was INR 2.39 compared to INR 2.8 a year ago. Diluted earnings per share from continuing operations was INR 2.39 compared to INR 2.8 a year ago.
For the full year, sales was INR 17,882.2 million compared to INR 16,400.5 million a year ago. Revenue was INR 18,271.4 million compared to INR 16,709.5 million a year ago. Net income was INR 984.7 million compared to INR 1,422.5 million a year ago. Basic earnings per share from continuing operations was INR 10.53 compared to INR 15.44 a year ago. Diluted earnings per share from continuing operations was INR 10.51 compared to INR 15.42 a year ago.